Alzheimer’s drug sparks emotional battle as FDA nears deadline on whether to approve: If cleared, the drug would be the first for slowing cognitive decline, but critics say the data does not prove it works

Alzheimer’s drug sparks emotional battle as FDA nears deadline on whether to approve: If cleared, the drug would be the first for slowing cognitive decline, but critics say the data does not prove it works
Alzheimer’s drug sparks emotional battle as FDA nears deadline on whether to approve: If cleared, the drug would be the first for slowing cognitive decline, but critics say the data does not prove it works submitted by /u/DoremusJessup
[link] [comments]
https://ift.tt/3fWEWYl June 01, 2021 at 11:10AM https://ift.tt/1R552o9

Comments

Popular posts from this blog

SC transfers PIL seeking implementation of law on mental health care to NHRC

Hospital-insurer conflict: Will latest circular by NMC help in reducing the pain of health insurance policyholders?

Over 9.19 crore hospital admissions facilitated under Ayushman Bharat since 2018